Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT) (2011)
- Authors:
- Autor USP: MARIN NETO, JOSE ANTONIO - FMRP
- Unidade: FMRP
- DOI: 10.1161/CIRCULATIONAHA.111.038943
- Subjects: INSUFICIÊNCIA RENAL AGUDA; ANGIOCARDIOGRAFIA; ANGIOPLASTIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Circulation
- ISSN: 0009-7322
- Volume/Número/Paginação/Ano: v. 124, n. 11, p. 1250-1259, 2011
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BERWANGER, Otavio e MARIN NETO , José Antonio. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT). Circulation, v. 124, n. 11, p. 1250-1259, 2011Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.111.038943. Acesso em: 23 jan. 2026. -
APA
Berwanger, O., & Marin Neto , J. A. (2011). Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT). Circulation, 124( 11), 1250-1259. doi:10.1161/CIRCULATIONAHA.111.038943 -
NLM
Berwanger O, Marin Neto JA. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT) [Internet]. Circulation. 2011 ; 124( 11): 1250-1259.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.111.038943 -
Vancouver
Berwanger O, Marin Neto JA. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT) [Internet]. Circulation. 2011 ; 124( 11): 1250-1259.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.111.038943 - Formacao e habilitacao do eletrofisiologista . Recomendacoes do departamento de arritmias e eletrofisiologia clinica (daec) da sociedade brasileira de cardiologia
- Uso precoce de B-bloqueador no infarto sem elevação ST: registro GRACE
- Thallium reinjection demonstrates viable myocardium in regions with reverse redistribution
- Controversias em medicina, conduta nas arritmias ventriculares em pacientes com insuficiencia cardiaca congestiva
- Basal insulin and cardiovascular and other outcomes in dysglycemia
- The occluded artery trial (OAT) viability ancillary study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone
- Benznidazole for chronic Chagas’ cardiomyopathy. [Carta]
- Comparação entre o conhecimento populacional a respeito de fatores de risco cardiovasculares e risco absoluto atribuível à população: PrevenAção e Interheart
- Panorama do uso de stents farmacológicos no Brasil: o registro CENIC
- Relatório SBC/Funcor: gestão 2006/2007
Informações sobre o DOI: 10.1161/CIRCULATIONAHA.111.038943 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
